{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:58:00Z","timestamp":1774976280551,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15723-x","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:47:43Z","timestamp":1771843663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of glycolysis -correlative features for predicting prognosis and investigating immune landscape in prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"1","key":"15723_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"2\u20133","key":"15723_CR2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10555-013-9473-1","volume":"33","author":"D Mukherji","year":"2014","unstructured":"Mukherji D, Omlin A, Pezaro C, Shamseddine A, de Bono J. Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics. Cancer Metastasis Rev. 2014;33(2\u20133):555\u201366.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"15723_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.euo.2020.05.004","volume":"4","author":"MP Deek","year":"2021","unstructured":"Deek MP, Taparra K, Phillips R, Velho PI, Gao RW, Deville C, et al. Metastasis-directed therapy prolongs efficacy of systemic therapy and improves clinical outcomes in oligoprogressive Castration-resistant prostate cancer. Eur Urol Oncol. 2021;4(3):447\u201355.","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"15723_CR4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","volume":"17","author":"DA Bader","year":"2020","unstructured":"Bader DA, McGuire SE. Tumour metabolism and its unique properties in prostate adenocarcinoma. Nat Rev Urol. 2020;17(4):214\u201331.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"15723_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Wenes M, Romero P, Huang SCC, Fendt SM, Ho PC. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol. 2019;16(7):425\u201341.","journal-title":"Nat Rev Clin Oncol"},{"key":"15723_CR6","doi-asserted-by":"crossref","first-page":"104511","DOI":"10.1016\/j.phrs.2019.104511","volume":"150","author":"AF Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019;150:104511.","journal-title":"Pharmacol Res"},{"issue":"3","key":"15723_CR7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.7150\/thno.50150","volume":"11","author":"MN Hasan","year":"2021","unstructured":"Hasan MN, Luo L, Ding D, Song S, Bhuiyan MIH, Liu R, et al. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells. Theranostics. 2021;11(3):1295\u2013309.","journal-title":"Theranostics"},{"key":"15723_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2020.02.034","volume":"477","author":"V Miranda-Gon\u00e7alves","year":"2020","unstructured":"Miranda-Gon\u00e7alves V, Lameirinhas A, Henrique R, Baltazar F, Jer\u00f3nimo C. The metabolic landscape of urological cancers: new therapeutic perspectives. Cancer Lett. 2020;477:76\u201387.","journal-title":"Cancer Lett"},{"issue":"2","key":"15723_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201\u2013e2189.","journal-title":"Cancer Cell"},{"issue":"12","key":"15723_CR10","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.7150\/thno.56490","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Lin F, Wan T, Chen A, Wang H, Jiang B, et al. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM. Theranostics. 2021;11(12):5926\u201338.","journal-title":"Theranostics"},{"issue":"3","key":"15723_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C, Lactate. A key regulator of the immune response. Immunity. 2025;58(3):535\u201354.","journal-title":"Immunity"},{"issue":"2","key":"15723_CR12","doi-asserted-by":"crossref","first-page":"e010787","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Wang D, Zhou G, Jiang S, Zhang G, Zhang L, et al. Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(2):e010787.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"15723_CR13","doi-asserted-by":"crossref","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye B, Fan J, Xue L, Zhuang Y, Luo P, Jiang A, et al. iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan\u2010cancer immunotherapy response prediction. Imeta. 2025;4(2):e70011.","journal-title":"Imeta"},{"issue":"1","key":"15723_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40364-024-00686-7","volume":"12","author":"J Feng","year":"2024","unstructured":"Feng J, Zhang P, Wang D, Li Y, Tan J. New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology. Biomark Res. 2024;12(1):136.","journal-title":"Biomark Res"},{"issue":"3","key":"15723_CR15","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms24032606","volume":"24","author":"C Chelakkot","year":"2023","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating Glycolysis to improve cancer therapy. Int J Mol Sci. 2023;24(3):2606.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"15723_CR16","doi-asserted-by":"crossref","first-page":"24983","DOI":"10.18632\/aging.103806","volume":"12","author":"J Tang","year":"2020","unstructured":"Tang J, Luo Y, Wu G. A glycolysis-related gene expression signature in predicting recurrence of breast cancer. Aging. 2020;12(24):24983\u201394.","journal-title":"Aging"},{"issue":"1","key":"15723_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12885-021-08111-0","volume":"21","author":"Q Xing","year":"2021","unstructured":"Xing Q, Zeng T, Liu S, Cheng H, Ma L, Wang Y. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. BMC Cancer. 2021;21(1):381.","journal-title":"BMC Cancer"},{"issue":"24","key":"15723_CR18","doi-asserted-by":"crossref","first-page":"25828","DOI":"10.18632\/aging.104206","volume":"12","author":"H Kang","year":"2020","unstructured":"Kang H, Wang N, Wang X, Zhang Y, Lin S, Mao G, et al. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma. Aging. 2020;12(24):25828\u201344.","journal-title":"Aging"},{"issue":"1","key":"15723_CR19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-021-03057-0","volume":"19","author":"J Bi","year":"2021","unstructured":"Bi J, Bi F, Pan X, Yang Q. Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment. J Transl Med. 2021;19(1):382.","journal-title":"J Transl Med"},{"key":"15723_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fimmu.2018.00053","volume":"9","author":"BR Yoon","year":"2018","unstructured":"Yoon BR, Oh YJ, Kang SW, Lee EB, Lee WW. Role of SLC7A5 in metabolic reprogramming of human Monocyte\/Macrophage immune responses. Front Immunol. 2018;9:53.","journal-title":"Front Immunol"},{"issue":"41","key":"15723_CR21","doi-asserted-by":"crossref","first-page":"e2305215","DOI":"10.1002\/adma.202305215","volume":"35","author":"P Zhang","year":"2023","unstructured":"Zhang P, Li Z, Cao W, Tang J, Xia Y, Peng L, et al. A PD-L1 Antibody-Conjugated PAMAM dendrimer nanosystem for simultaneously inhibiting Glycolysis and promoting immune response in fighting breast cancer. Adv Mater. 2023;35(41):e2305215.","journal-title":"Adv Mater"},{"issue":"10","key":"15723_CR22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"15723_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eururo.2013.08.011","volume":"66","author":"P Rajan","year":"2014","unstructured":"Rajan P, Sudbery IM, Villasevil MEM, Mui E, Fleming J, Davis M, et al. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Eur Urol. 2014;66(1):32\u20139.","journal-title":"Eur Urol"},{"key":"15723_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2021.09.036","volume":"160","author":"UM Vogl","year":"2022","unstructured":"Vogl UM, Beer TM, Davis ID, Shore ND, Sweeney CJ, Ost P, et al. Lack of consensus identifies important areas for future clinical research: advanced prostate cancer consensus conference (APCCC) 2019 findings. Eur J Cancer. 2022;160:24\u201360.","journal-title":"Eur J Cancer"},{"issue":"5","key":"15723_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215\u201328.","journal-title":"Cell"},{"issue":"11","key":"15723_CR26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41585-019-0237-8","volume":"16","author":"SY Ku","year":"2019","unstructured":"Ku SY, Gleave ME, Beltran H. Towards precision oncology in advanced prostate cancer. Nat Rev Urol. 2019;16(11):645\u201354.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"15723_CR27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eururo.2020.01.012","volume":"77","author":"S Gillessen","year":"2020","unstructured":"Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77(4):508\u201347.","journal-title":"Eur Urol"},{"key":"15723_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.006","volume":"518","author":"A Jamroze","year":"2021","unstructured":"Jamroze A, Chatta G, Tang DG. Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Lett. 2021;518:1\u20139.","journal-title":"Cancer Lett"},{"issue":"5","key":"15723_CR29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00261-015-0562-1","volume":"41","author":"EJ May","year":"2016","unstructured":"May EJ, Viers LD, Viers BR, Kawashima A, Kwon ED, Karnes RJ, et al. Prostate cancer post-treatment follow-up and recurrence evaluation. Abdom Radiol (NY). 2016;41(5):862\u201376.","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"15723_CR30","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/hed.26814","volume":"43","author":"T Uehara","year":"2021","unstructured":"Uehara T, Doi H, Ishikawa K, Inada M, Tatsuno S, Wada Y, et al. Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: retrospective study on predictive factors. Head Neck. 2021;43(10):3132\u201341.","journal-title":"Head Neck"},{"issue":"2","key":"15723_CR31","doi-asserted-by":"crossref","first-page":"100493","DOI":"10.1016\/j.xcrm.2021.100493","volume":"3","author":"SR Plymate","year":"2022","unstructured":"Plymate SR, Sprenger C, Haffner MC. Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymes. Cell Rep Med. 2022;3(2):100493.","journal-title":"Cell Rep Med"},{"issue":"Pt 3","key":"15723_CR32","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86(Pt 3):1216\u201330.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"15723_CR33","doi-asserted-by":"crossref","first-page":"100502","DOI":"10.1016\/j.xcrm.2021.100502","volume":"3","author":"MA Rice","year":"2022","unstructured":"Rice MA, Kumar V, Tailor D, Garcia-Marques FJ, Hsu EC, Liu S, et al. SU086, an inhibitor of HSP90, impairs Glycolysis and represents a treatment strategy for advanced prostate cancer. Cell Rep Med. 2022;3(2):100502.","journal-title":"Cell Rep Med"},{"issue":"3","key":"15723_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, Ho PC, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"15723_CR35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41375-021-01390-3","volume":"36","author":"AJ Pulikkottil","year":"2022","unstructured":"Pulikkottil AJ, Bamezai S, Ammer T, Mohr F, Feder K, Vegi NM, et al. TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways. Leukemia. 2022;36(2):416\u201325.","journal-title":"Leukemia"},{"issue":"7","key":"15723_CR36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang Y, Yang W, et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp Mol Med. 2023;55(7):1357\u201370.","journal-title":"Exp Mol Med"},{"key":"15723_CR37","doi-asserted-by":"crossref","first-page":"1047433","DOI":"10.3389\/fendo.2022.1047433","volume":"13","author":"W Huang","year":"2022","unstructured":"Huang W, Xiao Y, Wang H, Chen G, Li K. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma. Front Endocrinol (Lausanne). 2022;13:1047433.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"15723_CR38","doi-asserted-by":"crossref","first-page":"777507","DOI":"10.3389\/fmed.2021.777507","volume":"8","author":"T Li","year":"2022","unstructured":"Li T, Tong H, Zhu J, Qin Z, Yin S, Sun Y, et al. Identification of a Three-Glycolysis-Related LncRNA signature correlated with prognosis and metastasis in clear cell renal cell carcinoma. Front Med. 2022;8:777507.","journal-title":"Front Med"},{"issue":"12","key":"15723_CR39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41575-020-00368-3","volume":"17","author":"MA Hull","year":"2020","unstructured":"Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020;17(12):773\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"15723_CR40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4161\/cbt.28160","volume":"15","author":"S Karthikeyan","year":"2014","unstructured":"Karthikeyan S, Geschwind JF, Ganapathy-Kanniappan S. Tumor cells and memory T cells converge at glycolysis: therapeutic implications. Cancer Biol Ther. 2014;15(5):483\u20135.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"15723_CR41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.","journal-title":"Mol Cancer"},{"issue":"10","key":"15723_CR42","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","volume":"123","author":"M Sukumar","year":"2013","unstructured":"Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG, Yu Z, et al. Inhibiting glycolytic metabolism enhances CD8\u2009+\u2009T cell memory and antitumor function. J Clin Invest. 2013;123(10):4479\u201388.","journal-title":"J Clin Invest"},{"issue":"9","key":"15723_CR43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic Glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 2022;34(9):1312\u2013e13246.","journal-title":"Cell Metab"},{"issue":"5","key":"15723_CR44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1878-0261.12879","volume":"15","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang X, Huang S, Chen J, Ding P, Wang Q, et al. FOXM1D potentiates PKM2-mediated tumor Glycolysis and angiogenesis. Mol Oncol. 2021;15(5):1466\u201385.","journal-title":"Mol Oncol"},{"issue":"7","key":"15723_CR45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, et al. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in Glycolysis and tumorigenesis of bladder cancer. Cancer Commun (Lond). 2021;41(7):560\u201375.","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"15723_CR46","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1002\/jcb.26033","volume":"118","author":"C Wright","year":"2017","unstructured":"Wright C, Iyer AKV, Kaushik V, Azad N. Anti-Tumorigenic potential of a novel Orlistat-AICAR combination in prostate cancer cells. J Cell Biochem. 2017;118(11):3834\u201345.","journal-title":"J Cell Biochem"},{"key":"15723_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jare.2024.08.034","volume":"73","author":"M Chen","year":"2024","unstructured":"Chen M, Chen W, Sun S, Lu Y, Wu G, Xu H, et al. CDK4\/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells. J Adv Res. 2024;73:357\u201373.","journal-title":"J Adv Res"},{"issue":"8","key":"15723_CR48","doi-asserted-by":"crossref","first-page":"e965","DOI":"10.1002\/iid3.965","volume":"11","author":"H Zhu","year":"2023","unstructured":"Zhu H, Xu J, Li K, Chen M, Wu Y, Zhang X, et al. DOCK8 inhibits the immune function of neutrophils in sepsis by regulating aerobic Glycolysis. Immun Inflamm Dis. 2023;11(8):e965.","journal-title":"Immun Inflamm Dis"},{"key":"15723_CR49","doi-asserted-by":"crossref","first-page":"102575","DOI":"10.1016\/j.redox.2022.102575","volume":"59","author":"K Sen","year":"2023","unstructured":"Sen K, Pati R, Jha A, Mishra GP, Prusty S, Chaudhary S, et al. NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning Glycolysis and fatty acid oxidation. Redox Biol. 2023;59:102575.","journal-title":"Redox Biol"},{"issue":"4","key":"15723_CR50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41423-021-00806-5","volume":"19","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Fan G, Liu Y, Liu L, Zhang T, Liu P, et al. The transcription factor KLF14 regulates macrophage Glycolysis and immune function by inhibiting HK2 in sepsis. Cell Mol Immunol. 2022;19(4):504\u201315.","journal-title":"Cell Mol Immunol"},{"issue":"18","key":"15723_CR51","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.7150\/ijms.49652","volume":"17","author":"CC Wu","year":"2020","unstructured":"Wu CC, Ekanem TI, Phan NN, Loan DTT, Hou SY, Lee KH, et al. Gene signatures and prognostic analyses of the Tob\/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients. Int J Med Sci. 2020;17(18):3112\u201324.","journal-title":"Int J Med Sci"},{"issue":"5","key":"15723_CR52","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1002\/jcp.29312","volume":"235","author":"L Zhang","year":"2020","unstructured":"Zhang L, He M, Zhu W, Lv X, Zhao Y, Yan Y, et al. Identification of a panel of mitotic spindle-related genes as a signature predicting survival in lung adenocarcinoma. J Cell Physiol. 2020;235(5):4361\u201375.","journal-title":"J Cell Physiol"},{"key":"15723_CR53","doi-asserted-by":"crossref","first-page":"1138524","DOI":"10.3389\/fimmu.2023.1138524","volume":"14","author":"Z Xu","year":"2023","unstructured":"Xu Z, Pei C, Cheng H, Song K, Yang J, Li Y, et al. Comprehensive analysis of FOXM1 immune infiltrates, m6a, Glycolysis and CeRNA network in human hepatocellular carcinoma. Front Immunol. 2023;14:1138524.","journal-title":"Front Immunol"},{"key":"15723_CR54","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.2147\/JIR.S481835","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Wang R, Liu Y, Yang B, Wang H. RNA sequencing reveals that the genes related to cell cycle and Glycolysis play an essential role in IL-27-Induced keratinocyte hyperproliferation. J Inflamm Res. 2024;17:8165\u201380.","journal-title":"J Inflamm Res"},{"key":"15723_CR55","doi-asserted-by":"crossref","first-page":"1386427","DOI":"10.3389\/fimmu.2024.1386427","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang J, Zuo C, Chen H, Wang L, Xie Y, et al. Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1. Front Immunol. 2024;15:1386427.","journal-title":"Front Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15723-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:48:56Z","timestamp":1774972136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15723-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15723"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15723-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. 20241801) and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}